Volume 3, Supplement 1 (May 1997)

Herpes simplex virus virulence: the functions of the gamma (1)34.5 gene
Roizman B, Markovitz N.
pp. S1-2

Molecular and cellular aspects of measles virus persistence in the CNS ter
Meulen V.
pp. S3-5

Use of primary CNS cultures to investigate HIV neurotropism
Gonzalez-Scarano F, Strizki JM, Albright A, Shieh J
pp. S11-3

HIV neuropathogenesis
Levy JA.
pp. S14-5

Neurobiology of Borna disease virus
Lipkin WI, Hatalski CG, Briese T.
pp. S17-20

Neurotoxicity and neuroinvasiveness of prions
Aguzzi A, Raeber A, Blattler T, Flechsig E, Klein M, Weissmann C, Brandner S.
pp. S23-4

The regulation of gene expression in neurotrophic viruses
Roos RP.
pp. S25-7

Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat
Krebs FC, Goodenow MM, Wigdahl B.
pp. S28-32

Modulation of mouse hepatitis virus infection by defective-interfering RNA-mediated expression of viral proteins and cytokines
Lai MM, Zhang X, Hinton D, Stohlman S.
pp. S33-4

Determinants of poliovirus neurovirulence
Gromeier M, Mueller S, Solecki D, Bossert B, Bernhardt G, Wimmer E.
pp. S35-8

Alzheimer's disease: a dissection of its etiology
Jay G.
pp. S41-2

The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis
Rodriguez M, Rivera-Quinones C, Murray PD, Kariuki Njenga M, Wettstein PJ, Mak T.
pp. S43-5

Molecular epidemiology and emerging infectious diseases of the nervous system
Weber T.
pp. S46-9

Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV
Osame M, Nakagawa M, Umehara F, Ijichi S, Moritoyo T, Higuchi I, Usuku K, Arimura K, Izumo S.
pp. S50-1

Molecular epidemiology of rabies in the United States: reemergence of a classical neurotropic agent
Rupprecht CE, Smith JS, Krebs JW, Childs JE.
pp. S52-3

A genetic approach to study the pathogenesis of Theiler's virus persistent infection
Azoulay-Cayla A, Brahic M, Bureau JF, Bihl F, Dethlefs S, Fiette L, Jarousse N, Larsson-Sciard EL, Martinat C, McAllister A, Michiels T, Pena Rossi C.
pp. 55

Immune regulation of coronavirus-induced demyelinating encephalomyelitis
Stohlman SA, Lin M, Parra B, Bergmann CC, Hinton DR.
pp. S56-7

Signaling pathways in virus-induced CNS inflammation
Dietzschold B, Morimoto K.
pp. S58-9

Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus
Miller SD, Vanderlugt CL, Begolka WS, Pao W, Neville KL, Yauch RL, Kim BS.
pp.S62-5

Lack of correlation of Theiler's virus binding to cells with infection.
McCright IJ, Fujinami RS.
pp. S68-70

Alternative delivery systems for antiviral nucleosides and antisense oligonucleotides to the brain.
Levy RM, Ward S, Schalgeter K, Groothuis D.
pp. S74-5

Viruses and oncogenes in brain tumors.
Archer GE, Sampson JH, Bigner DD.
pp. S76-7

SV40 and human brain tumors.
Butel JS, Lednicky JA, Stewart AR, Garcea RL, Finegold MJ.
pp. S78-9